Efficacy and safety profile of dronedarone in clinical practice. Results of the Magdeburg Dronedarone Registry (MADRE study)

International Journal of Cardiology

Volumn 167, Issue 6, 2013, Pages 2600-2604

  Said, Samir M ^a   Esperer, Hans D ^a   Kluba, Kathrin ^a   Genz, Conrad ^a   Wiedemann, Anne K ^a   Boenigk, Hagen ^a   Herold, Joerg ^a   Schmeisser, Alexander ^a   Braun Dullaeus, Ruediger C ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Adverse drug events; Antiarrhythmic drugs; Atrial fibrillation; Dronedarone

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CREATINE KINASE; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRONEDARONE; ELECTROLYTE; FLECAINIDE; LIVER ENZYME; PROPAFENONE; SOTALOL; STATIN (PROTEIN);

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BRADYCARDIA; CARDIOVERSION; CLINICAL PRACTICE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIARRHEA; DISEASE REGISTRY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAM; ELECTROLYTE BLOOD LEVEL; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART VENTRICLE EXTRASYSTOLE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NAUSEA; PAROXYSMAL HEART ATRIUM FIBRILLATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QT PROLONGATION; RECURRENT DISEASE; REPEAT PROCEDURE; SIDE EFFECT; SINUS RHYTHM; SKIN DISEASE; TREATMENT RESPONSE;

ADVERSE DRUG EVENTS; ANTIARRHYTHMIC DRUGS; ATRIAL FIBRILLATION; DRONEDARONE;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL DISEASES; GERMANY; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; TREATMENT OUTCOME;

EID: 84883799025     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.06.056     Document Type: Article

References (19)

1. A.S. Go, E.M. Hylek, and K.A. Phillips Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375
2. A. García-Castelo, J. García-Seara, and F. Otero-Raviña Porgnostic impact of atrial fibrillation progression in a community study:AFBAR Study Int J Cardiol 153 2011 68 73
3. J. Camm Antiarrhythmic drugs for the maintenance of sinus rhythm: risk and benefits Int J Cardiol 155 2012 362 371
4. Drondedarone approval letter 2009 Food and Drug Administration Rockville, MD [Available at: www.fda.gov. Accessed January 09, 2012]
5. Dronedarone: drug information 2009 European Medicines Agency Canary Wharf, London [Available at www.emea.europa.eu. Accessed January 09, 2012]
6. S.H. Hohnloser, H.J. Crijns, and M. van Eickels Effect of dronedarone on cardiovascular events in atrial fibrillation N Engl J Med 360 2009 668 678
7. Cardiovascular and renal drugs advisory committee meeting. NDA 22-425, Dronedarone 400 milligrams oral tablets 2009 Food and Drug Aministration Rockville, MD [Available at: www.fda.gov. Accessed January 09, 2012]
8. W. Sun, J.S. Sarma, and B.N. Singh Chronic and acute effects of dronedarone on the action potential of rabbit atrial muscle preparations: comparison with amiodarone J Cardiovasc Pharmacol 39 2002 677 684
9. S.M. Said, H.D. Esperer, K. Kluba, C. Genz, A.K. Wiedemann, and H. Boenigk Efficacy and safety profile of dronedarone in clinical practice. Preliminary results of the Magdeburg Dronedarone Registry Int J Cardiol 157 2012 303 304
10. L.S. Wann, A.B. Curtis, and C.T. January 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline) J Am Coll Cardiol 57 2011 223 242
11. B.N. Singh, S.J. Connolly, and H.J. Crijns Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter N Engl J Med 357 2007 987 999
12. J.Y. Le Heuzey, G.M. De Ferrari, and D. Radzik A short-term, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of dronedarone versus amiodarone in patients with persistent atrial fibrillation: the DIONYSOS study J Cardiovasc Electrophysiol 21 2010 597 605
13. D. Roy, M. Talajic, P. Dorian, and S. Connolly Amiodarone to prevent recurrence of atrial fibrillation N Engl J Med 342 2000 913 920
14. I.A. Khan Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation Int J Cardiol 87 2003 121 128
15. P. Gautier, M. Serre, and S. Cosnier-Pucheu In vivo and in vitro antiarrhythmic effects of SSR149744C in animal models of atrial fibrillation and ventricular arrhythmias J Cardiovasc Pharmacol 45 2005 125 135
16. R. Bogdan, H. Goegelein, and H. Ruetten Effect of dronedarone on Na+, Ca2+ and HCN channels Naunyn Schmiedebergs Arch Pharmacol 383 2011 347 356
17. S.J. Connolly, A.J. Camm, and J.L. Halperin Dronedarone in high-risk permanent atrial fibrillation N Engl J Med 365 2011 2268 2276
18. D. Singh, E. Cingolani, and G.A. Diamond Dronedarone for atrial fibrillation have we expanded the antiarrhythmic armamentarium? J Am Coll Cardiol 55 2010 1569 1576
19. B.N. Singh, S.N. Singh, and D.J. Reda Amiodarone versus Sotalol for atrial fibrillation N Engl J Med 352 2005 1861 1872